Epithelial stem cells of the prostate and their role in cancer progression

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 73, Issue , 2008, Pages 491-502

  Lukacs, R U ^a   Lawson, D A ^a   Xin, L ^a   Zong, Y ^a   Garraway, I ^b   Goldstein, A S ^b   Memarzadeh, S ^b   Witte, O N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIANDROGEN;

AUTOCRINE EFFECT; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL POPULATION; CELL TYPE; CONFERENCE PAPER; DISEASE MARKER; GENE OVEREXPRESSION; HORMONAL THERAPY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYME; MICROARRAY ANALYSIS; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; SIGNAL TRANSDUCTION; STEM CELL; TISSUE REGENERATION; CELL FUNCTION; CFU COUNTING; HUMAN CELL CULTURE; INTRACELLULAR SPACE; PROSTATE EPITHELIUM CELL; STEM CELL SELF-RENEWAL; ADULT; ADULT STEM CELL; ANIMAL; BIOLOGICAL MODEL; CLONOGENIC ASSAY; CULTURE TECHNIQUE; CYTOLOGY; EPITHELIUM CELL; GENETICS; METABOLISM; MOUSE; PATHOLOGY; PROSTATE; PROSTATE TUMOR; REGENERATION; REVIEW;

ADULT; ADULT STEM CELLS; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; COLONY-FORMING UNITS ASSAY; EPITHELIAL CELLS; HUMANS; MALE; MICE; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; PROSTATE; PROSTATIC NEOPLASMS; REGENERATION;

EID: 68549135412     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2008.73.012     Document Type: Conference Paper

References (111)

1. Abate-Shen, C. and Shen, M.M. 2000. Molecular genetics of prostate cancer. Genes Dev. 14: 2410-2434.
2. Abrahamsson, P.A. 1999. Neuroendocrine differentiation in prostatic carcinoma. Prostate 39: 135-148.
3. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., and Clarke, M.F. 2003. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. 100: 3983-3988.
4. Aumuller, G., Leonhardt, M., Janssen, M., Konrad, L., Bjartell, A., and Abrahamsson, P.A. 1999. Neurogenic origin of human prostate endocrine cells. Urology 53: 1041-1048.
5. Azuma, M., Hirao, A., Takubo, K., Hamaguchi, I., Kitamura, T., and Suda, T. 2005. A quantitative matrigel assay for assessing repopulating capacity of prostate stem cells. Biochem. Biophys. Res. Commun. 338: 1164-1170.
6. Banerjee, P.P., Banerjee, S., Zirkin, B.R., and Brown, T.R. 1998. Lobe-specific telomerase activity in the intact adult brown Norway rat prostate and its regional distribution within the prostatic ducts. Endocrinology 139: 513-519.
7. Beachy, P.A., Karhadkar, S.S., and Berman, D.M. 2004. Tissue repair and stem cell renewal in carcinogenesis. Nature 432: 324-331.
8. Bello-DeOcampo, D., Kleinman, H.K., Deocampo, N.D., and Webber, M.M. 2001. Laminin-1 and α6β1 integrin regulate acinar morphogenesis of normal and malignant human prostate epithelial cells. Prostate 46: 142-153.
9. Bhatt, R.I., Brown, M.D., Hart, C.A., Gilmore, P., Ramani, V.A., George, N.J., and Clarke, N.W. 2003. Novel method for the isolation and characterisation of the putative prostatic stem cell. Cytometry A 54: 89-99.
10. Blanpain, C., Horsley, V., and Fuchs, E. 2007. Epithelial stem cells: Turning over new leaves. Cell 128: 445-458.
11. Bohlander, S.K. 2005. ETV6: A versatile player in leukemogenesis. Semin. Cancer Biol. 15: 162-174.
12. Bonkhoff, H. 1998. Neuroendocrine cells in benign and malignant prostate tissue: Morphogenesis, proliferation, and androgen receptor status. Prostate Suppl. 8: 18-22.
13. Bonkhoff, H. and Remberger, K. 1996. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model. Prostate 28: 98-106.
14. Bonnet, D. and Dick, J.E. 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3: 730-737.
15. Bradley, T.R. and Metcalf, D. 1966. The growth of mouse bone marrow cells in vitro. Aust. J. Exp. Biol. Med. Sci. 44: 287-299.
16. Brown, M.D., Gilmore, P.E., Hart, C.A., Samuel, J.D., Ramani, V.A., George, N.J., and Clarke, N.W. 2007. Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations. Prostate 67: 1384-1396.
17. Bruce, W.R. and Van Der Gaag, H. 1963. A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 199: 79-80.
18. Bunting, K.D. 2002. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 20: 11-20.
19. Burger, P.E., Xiong, X., Coetzee, S., Salm, S.N., Moscatelli, D., Goto, K., and Wilson, E.L. 2005. Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc. Natl. Acad. Sci. 102: 7180-7185.
20. Collins, A.T., Habib, F.K., Maitland, N.J., and Neal, D.E. 2001. Identification and isolation of human prostate epithelial stem cells based on α(2)β(1)-integrin expression. J. Cell Sci. 114: 3865-3872.
21. Collins, A.T., Berry, P.A., Hyde, C., Stower, M.J., and Maitland, N.J. 2005. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65: 10946-10951.
22. Corti, S., Nizzardo, M., Nardini, M., Donadoni, C., Locatelli, F., Papadimitriou, D., Salani, S., Del Bo, R., Ghezzi, S., Strazzer, S., et al. 2007. Isolation and characterization of murine neural stem/progenitor cells based on Prominin-1 expression. Exp. Neurol. 205: 547-562.
23. Cotsarelis, G., Sun, T.T., and Lavker, R.M. 1990. Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61: 1329-1337.
24. Cozzio, A., Passegue, E., Ayton, P.M., Karsunky, H., Cleary, M.L., and Weissman, I.L. 2003. Similar MLL-associated leukemias arising from self-renewing stem cells and shortlived myeloid progenitors. Genes Dev. 17: 3029-3035.
25. Cunha, G.R. and Lung, B. 1978. The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. J. Exp. Zool. 205: 181-193.
26. Cunha, G.R., Donjacour, A.A., Cooke, P.S., Mee, S., Bigsby, R.M., Higgins, S.J., and Sugimura, Y. 1987. The endocrinology and developmental biology of the prostate. Endocr. Rev. 8: 338-362.
27. Deocampo, N.D., Huang, H., and Tindall, D.J. 2003. The role of PTEN in the progression and survival of prostate cancer. Minerva Endocrinol. 28: 145-153.
28. DiGiovanni, J., Bol, D.K., Wilker, E., Beltran, L., Carbajal, S., Moats, S., Ramirez, A., Jorcano, J., and Kiguchi, K. 2000. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res. 60: 1561-1570.
29. Dong, B., Kim, S., Hong, S., Das Gupta, J., Malathi, K., Klein, E.A., Ganem, D., Derisi, J.L., Chow, S.A., and Silverman, R.H. 2007. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc. Natl. Acad. Sci. 104: 1655-1660.
30. Dontu, G., Abdallah, W.M., Foley, J.M., Jackson, K.W., Clarke, M.F., Kawamura, M.J., and Wicha, M.S. 2003. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17: 1253-1270.
31. Duvillie, B., Attali, M., Aiello, V., Quemeneur, E., and Scharfmann, R. 2003. Label-retaining cells in the rat pancreas: Location and differentiation potential in vitro. Diabetes 52: 2035-2042.
32. English, H.F., Santen, R.J., and Isaacs, J.T. 1987. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11: 229-242.
33. Evans, G.S. and Chandler, J.A. 1987. Cell proliferation studies in the rat prostate. II. The effects of castration and androgeninduced regeneration upon basal and secretory cell proliferation. Prostate 11: 339-351.
34. Feldman, B.J. and Feldman, D. 2001. The development of androgen-independent prostate cancer. Nat. Rev. Cancer 1: 34-45.
35. Ford, C.E., Hamerton, J.L., Barnes, D.W., and Loutit, J.F. 1956. Cytological identification of radiation-chimaeras. Nature 177: 452-454.
36. Fortunel, N.O., Out, H.H., Ng, H.H., Chen, J., Mu, X., Chevassut, T., Li, X., Joseph, M., Bailey, C., Hatzfeld, J.A., et al. 2003. Comment on " 'Stemness': Transcriptional profiling of embryonic and adult stem cells" and "a stem cell molecular signature." Science 302: 393; author reply 393.
37. Glinsky, G.V., Berezovska, O., and Glinskii, A.B. 2005. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 115: 1503-1521.
38. Goto, K., Salm, S.N., Coetzee, S., Xiong, X., Burger, P.E., Shapiro, E., Lepor, H., Moscatelli, D., and Wilson, E.L. 2006. Proximal prostatic stem cells are programmed to regenerate a proximal-distal ductal axis. Stem Cells 24: 1859-1868.
39. Gu, G., Yuan, J., Wills, M., and Kasper, S. 2007. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res. 67: 4807-4815.
40. Harding, M.A. and Theodorescu, D. 2000. Prostate tumor progression and prognosis. Interplay of tumor and host factors. Urol. Oncol. 5: 258-264.
41. Harrison, D.E. 1980. Competitive repopulation: A new assay for long-term stem cell functional capacity. Blood 55: 77-81.
42. Hewitt, H.B., Blake, E., and Proter, E.H. 1973. The effect of lethally irradiated cells on the transplantability of murine tumours. Br. J. Cancer 28: 123-135.
43. Hill, R.P. 2006. Identifying cancer stem cells in solid tumors: Case not proven. Cancer Res. 66: 1891-1895; discussion 1890.
44. Hong, K.U., Reynolds, S.D., Giangreco, A., Hurley, C.M., and Stripp, B.R. 2001. Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am. J. Respir. Cell Mol. Biology 24: 671-681.
45. Hudson, D.L., O'Hare, M., Watt, F.M., and Masters, J.R. 2000. Proliferative heterogeneity in the human prostate: Evidence for epithelial stem cells. Lab. Invest. 80: 1243-1250.
46. Hudson, D.L., Guy, A.T., Fry, P., O'Hare, M.J., Watt, F.M., and Masters, J.R. 2001. Epithelial cell differentiation pathways in the human prostate: Identification of intermediate phenotypes by keratin expression. J. Histochem. Cytochem. 49: 271-278.
47. Huggins, C. and Hodges, C. 1941. Studies on prostatic cancer. I. The effects of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1: 293-297.
48. Huntly, B.J., Shigematsu, H., Deguchi, K., Lee, B.H., Mizuno, S., Duclos, N., Rowan, R., Amaral, S., Curley, D., Williams, I.R., et al. 2004. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6: 587-596.
49. Isaacs, J.T. 1987. Control of cell proliferation and cell death in the normal and neoplastic prostate: A stem cell model. In Benign prostatic hyperplasia (ed. C.H. Rogers et al.), pp. 85-94. National Institutes of Health, Bethesda, Maryland. Isaacs, J.T. and Coffey, D.S. 1989. Etiology and disease process of benign prostatic hyperplasia. Prostate 2: 33-50.
50. Ivanova, N.B., Dimos, J.T., Schaniel, C., Hackney, J.A., Moore, K.A., and Lemischka, I.R. 2002. A stem cell molecular signature. Science 298: 601-604.
51. Jamieson, C.H., Ailles, L.E., Dylla, S.J., Muijtjens, M., Jones, C., Zehnder, J.L., Gotlib, J., Li, K., Manz, M.G., Keating, A., et al. 2004. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351: 657-667.
52. Karhadkar, S.S., Bova, G.S., Abdallah, N., Dhara, S., Gardner, D., Maitra, A., Isaacs, J.T., Berman D.M., and Beachy, P.A. 2004. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431: 707-712.
53. Kellokumpu-Lehtinen, P., Santti, R., and Pelliniemi, L.J. 1979. Early cytodifferentiation of human prostatic urethra and Leydig cells. Anat. Rec. 194: 429-443.
54. Kim, C.F., Jackson, E.L., Woolfenden, A.E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R.T., and Jacks, T. 2005. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835.
55. Klein, R.D. 2005. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research. Mutat. Res. 576: 111-119.
56. Kordon, E.C. and Smith, G.H. 1998. An entire functional mammary gland may comprise the progeny from a single cell. Development 125: 1921-1930.
57. Kovar H. 2005. Context matters: The hen or egg problem in Ewing's sarcoma. Semin. Cancer Biol. 15: 189-196.
58. Kyprianou, N. and Isaacs, J.T. 1988. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122: 552-562.
59. Lang, S.H., Sharrard, R.M., Stark, M., Villette, J.M., and Maitland, N.J. 2001. Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in threedimensional Matrigel cultures. Br. J. Cancer 85: 590-599.
60. Lawson, D.A., Xin, L., Lukacs, R.U., Cheng, D., and Witte, O.N. 2007. Isolation and functional characterization of murine prostate stem cells. Proc. Natl. Acad. Sci. 104: 181-186.
61. Lemischka, I.R., Raulet, D.H., and Mulligan, R.C. 1986. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 45: 917-927.
62. Litvinov, I.V., De Marzo, A.M., and Isaacs, J.T. 2003. Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling? J. Clin. Endocrinol. Metab. 88: 2972-2982.
63. Liu, A.Y., True, L.D., LaTray, L., Ellis, W.J., Vessella, R.L., Lange, P.H., Higano, C.S., Hood, L., and van den Engh, G. 1999. Analysis and sorting of prostate cancer cell types by flow cytometry. Prostate 40: 192-199.
64. Lois, C. and Alvarez-Buylla, A. 1993. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc. Natl. Acad. Sci. 90: 2074-2077.
65. Ma, X., Ziel-van der Made, A.C., Autar, B., van der Korput, H.A., Vermeij, M., van Duijn, P., Cleutjens, K.B., de Krijger, R., Krimpenfort, P., Berns, A. et al. 2005. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res. 65: 5730-5739.
66. Majumder, P.K., Yeh, J.J., George, D.J., Febbo, P.G., Kum, J., Xue, Q., Bikoff, R., Ma, H., Kantoff, P.W., Golub, T.R., et al. 2003. Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model. Proc. Natl. Acad. Sci. 100: 7841-7846.
67. McCulloch, E.A. and Till, J.E. 1960. The radiation sensitivity of normal mouse bone marrow cells, determined by quantitative marrow transplantation into irradiated mice. Radiat. Res. 13: 115-125.
68. Memarzadeh, S., Xin, L., Mulholland, D.J., Mansukhani, A., Wu, H., Teitell, M.A., and Witte, O.N. 2007. Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell 12: 572-585.
69. Nagle, R.B., Ahmann, F.R., McDaniel, K.M., Paquin, M.L., Clark, V.A., and Celniker, A. 1987. Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res. 47: 281-286.
70. Pascal, L.E., Oudes, A.J., Petersen, T.W., Goo, Y.A., Walashek, L.S., True, L.D., and Liu, A.Y. 2007. Molecular and cellular characterization of ABCG2 in the prostate. BMC Urol. 7: 6.
71. + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25: 1696-1708.
72. + cell population is enriched in tumor-initiating cells. Cancer Res. 67: 6796-6805.
73. Peters, L.J. and Hewitt, H.B. 1974. The influence of fibrin formation on the transplantability of murine tumour cells: Implications for the mechanism of the Revesz effect. Br. J. Cancer 29: 279-291.
74. Ploemacher, R.E., van der Sluijs, J.P., Voerman, J.S., and Brons, N.H. 1989. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 74: 2755-2763.
75. Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R.C., and Melton, D.A. 2002. "Stemness": Transcriptional profiling of embryonic and adult stem cells. Science 298: 597-600.
76. Reiter, R.E., Gu, Z., Watabe, T., Thomas, G., Szigeti, K., Davis, E., Wahl, M., Nisitani, S., Yamashiro, J., Le Beau, M.M., et al. 1998. Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer. Proc. Natl. Acad. Sci. 95: 1735-1740.
77. Reya, T., Morrison, S.J., Clarke, M.F., and Weissman, I.L. 2001. Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
78. Reynolds, B.A. and Weiss, S. 1996. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. 175: 1-13.
79. Richardson, G.D., Robson, C.N., Lang, S.H., Neal, D.E., Maitland, N.J., and Collins, A.T. 2004. CD133, a novel marker for human prostatic epithelial stem cells. J. Cell Sci. 117: 3539-3545.
80. -/- mice. Cancer Cell 6: 229-240.
81. Shackleton, M., Vaillant, F., Simpson, K.J., Stingl, J., Smyth, G.K., Asselin-Labat, M.L., Wu, L., Lindeman, G.J., and Visvader, J.E. 2006. Generation of a functional mammary gland from a single stem cell. Nature 439: 84-88.
82. Shi, X., Gipp, J., and Bushman, W. 2007. Anchorage-independent culture maintains prostate stem cells. Dev. Biol. 312: 396-406.
83. Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D., and Dirks, P.B. 2004. Identification of human brain tumour initiating cells. Nature 432: 396-401.
84. Southam, C.M., Burchenal, J.H., Clarkson, B., Tanzi, A., Mackey, R., and McComb, V. 1969. Heterotransplantability of human cell lines derived from leukemia and lymphomas into immunologically tolerant rats. Cancer 24: 211-222.
85. Spangrude, G.J., Heimfeld, S., and Weissman, I.L. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241: 58-62.
86. Stiles, B., Groszer, M., Wang, S., Jiao, J., and Wu, H. 2004. PTENless means more. Dev. Biol. 273: 175-184.
87. Stingl, J., Eirew, P., Ricketson, I., Shackleton, M., Vaillant, F., Choi, D., Li, H.I., and Eaves, C.J. 2006. Purification and unique properties of mammary epithelial stem cells. Nature 439: 993-997.
88. Sugimura, Y., Cunha, G.R., and Donjacour, A.A. 1986. Morphogenesis of ductal networks in the mouse prostate. Biol. Reprod. 34: 961-971.
89. Sun, M., Wang, G., Paciga, J.E., Feldman, R.I., Yuan, Z.Q., Ma, X.L., Shelley, S.A., Jove, R., Tsichlis, P.N., Nicosia, S.V., et al. 2001. AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am. J. Pathol. 159: 431-437.
90. Till, J.E. and McCulloch, E. 1961. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14: 213-222.
91. Tomlins, S.A., Rhodes, D.R., Perner, S., Dhanasekaran, S.M., Mehra, R., Sun, X.W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648.
92. Tomlins, S.A., Laxman, B., Dhanasekaran, S.M., Helgeson, B.E., Cao, X., Morris, D.S., Menon, A., Jing, X., Cao, Q., Han, B., et al. 2007. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448: 595-599.
93. Tomlins, S.A., Laxman, B., Varambally, S., Cao, X., Yu, J., Helgeson, B.E., Cao, Q., Prensner, J.R., Rubin, M.A., Shah, R.B., et al. 2008. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 10: 177-188.
94. Tran, C.P., Lin, C., Yamashiro, J., and Reiter, R.E. 2002. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol. Cancer Res. 1: 113-121.
95. Tsujimura, A., Koikawa, Y., Salm, S., Takao, T., Coetzee, S., Moscatelli, D., Shapiro, E., Lepor, H., Sun, T.T., and Wilson, E.L. 2002. Proximal location of mouse prostate epithelial stem cells: A model of prostatic homeostasis. J. Cell Biol. 157: 1257-1265.
96. Uzgare, A.R., Xu, Y., and Isaacs, J.T. 2004. In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue. J. Cell Biochem. 91: 196-205.
97. Verhagen, A.P., Ramaekers, F.C., Aalders, T.W., Schaafsma, H.E., Debruyne, F.M., and Schalken, J.A. 1992. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res. 52: 6182-6187.
98. Virchow, R. 1855. Editorial. In Archiv fuer pathologisce anatomie und physiologie und klinische medizin, p. 23.
99. Wang, Y., Hayward, S., Cao, M., Thayer, K., and Cunha, G. 2001. Cell differentiation lineage in the prostate. Differentiation 68: 270-279.
100. Wang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G.V., Li, G., Roy-Burman, P., Nelson, P.S., et al. 2003. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4: 209-221.
101. Wang, X.D., Leow, C.C., Zha, J., Tang, Z., Modrusan, Z., Radtke, F., Aguet, M., de Sauvage, F.J., and Gao, W.Q. 2006. Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation. Dev. Biol. 290: 66-80.
102. Webber, M.M., Bello, D., Kleinman, H.K., and Hoffman, M.P. 1997. Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells. Carcinogenesis 18: 1225-1231.
103. pos cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol. 245: 42-56.
104. Wernert, N., Seitz, G., and Achtstatter, T. 1987. Immunohistochemical investigation of different cytokeratins and vimentin in the prostate fromthe fetal period up to adulthood and in prostate carcinoma. Pathol. Res. Pract. 182: 617-626.
105. Wicha, M.S., Liu, S., and Dontu, G. 2006. Cancer stem cells: An old idea - A paradigm shift. Cancer Res. 66: 1883-1890; discussion 1895-1896.
106. Xie, X., Luo, Z., Slawin, K.M., and Spencer, D.M. 2004. The EZC-prostate model: Noninvasive prostate imaging in living mice. Mol. Endocrinol. 18: 722-732.
107. Xin, L., Ide, H., Kim, Y., Dubey, P., and Witte, O.N. 2003. In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc. Natl. Acad. Sci. (suppl. 1) 100: 11896-11903.
108. Xin, L., Lawson, D.A., and Witte, O.N. 2005. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc. Natl. Acad. Sci. 102: 6942-6947.
109. Xin, L., Teitell,M.A., Lawson,D.A.,Kwon,A.,Mellinghoff, I.K., and Witte, O.N. 2006. Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor. Proc. Natl. Acad. Sci. 103: 7789-7794.
110. Xin, L., Lukacs, R.U., Lawson, D.A., Cheng, D., and Witte, O.N. 2007. Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 25: 2760-2769.
111. Zhou, Z., Flesken-Nikitin, A., and Nikitin, A.Y. 2007. Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts. Cancer Res. 67: 5683-5690.